tenidap has been researched along with Pituitary Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cleveland, PL; Fewtrell, CM; Millard, PJ; Showell, HJ | 1 |
1 other study(ies) available for tenidap and Pituitary Neoplasms
| Article | Year |
|---|---|
Tenidap: a novel inhibitor of calcium influx in a mast cell line.
Topics: Animals; Antigens; Calcium; Calcium Channels; Indoles; Inositol Phosphates; Leukemia, Basophilic, Acute; Mast Cells; Mice; Oxindoles; Phosphatidylinositols; Pituitary Neoplasms; Rats; Signal Transduction; Terpenes; Thapsigargin; Tumor Cells, Cultured | 1993 |